Skip to main content
    F

    Fresenius Medical Care Corporation (FMS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $21.70
    -0.16 (-0.75%)

    Market Cap: $11.43B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Fresenius Medical Care Corporation (FMS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Fresenius Medical Care (FMS) has a market cap of $11.43B. Its share count is down 10.38% from a year earlier. Its dividend yield is 4.02%.

    Total Valuation

    Market Cap$11.43B
    Latest price (Nov 17, 2026)$21.70

    Key Dates

    The last ex-dividend date was May 22, 2026.

    Last Earnings DateNov 3, 2026
    Last Ex-Dividend DateMay 22, 2026
    Last Payment DateJun 8, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.82% in the quarter ended Sep 30, 2026 and shrank 5.50% a year over 2 years.

    Shares Outstanding524.00M
    Shares Change (YoY)-10.38%
    Shares Change (QoQ)-2.82%
    Share Count Growth (2Y CAGR)-5.50%

    Valuation Ratios

    Sales and book value multiples are 0.5x and 0.8x.

    P/E Ratio8.8x
    P/S Ratio0.5x
    P/B Ratio0.8x
    P/FCF Ratio5.6x
    PEG Ratio0.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.4x EBITDA and 9.1x free cash flow.

    EV / EBITDA5.4x
    EV / FCF9.1x

    Price Statistics

    The stock is down 7.25% over 52 weeks and trades 2.52% below its 50-day average.

    Beta (1Y)0.08
    52-Week Change-7.25%
    1-Month Change-1.12%
    3-Month Change-9.00%
    6-Month Change+2.12%
    5-Year Change-32.38%
    10-Year Change-44.63%
    Total Return (1Y)-3.52%
    Total Return (3Y CAGR)+5.13%
    Total Return (5Y CAGR)-5.54%
    Return vs SPY (1Y)-17.03%
    Max Drawdown (1Y)-19.50%
    Max Drawdown (3Y)-34.19%
    Sharpe Ratio (1Y)-0.18
    Correlation with SPY (1Y)0.04
    50-Day Average$22.26
    200-Day Average$22.56
    52-Week Range$19.24 to $26.42
    RSI (14 Days)43.9
    Average Volume (20 Days)1.54M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.99x current liabilities, and total debt is 0.59x shareholder equity.

    Current Ratio0.99x
    Quick Ratio0.69x
    Debt / Equity0.59x
    Debt / EBITDA2.49x
    Interest Coverage4.59x

    Returns and Efficiency

    Return on invested capital is 6.88% over the last 12 months, against a 5-year average of 5.25%.

    Return on Equity (ROE)6.56%
    Return on Assets (ROA)2.67%
    Return on Invested Capital (ROIC)6.88%
    Return on Capital Employed (ROCE)7.54%
    ROE (5Y Average)5.33%
    ROA (5Y Average)2.19%
    ROIC (5Y Average)5.25%
    Asset Turnover0.62x
    Inventory Turnover6.11x
    Receivables Turnover5.70x
    Cash Conversion Cycle101 days

    Taxes

    Income tax took 22.61% of pretax income over the last 12 months.

    Income Tax (TTM)EUR 316.86M
    Effective Tax Rate22.61%

    Scores

    FMS has an Altman Z-Score of 1.70, in the distress zone below 1.81, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score1.70
    Altman Z ZoneDistress
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of EUR 19.48B over the last 12 months is down 0.83% from the 12 months before.

    RevenueEUR 19.48B
    Revenue Growth (YoY)-0.83%
    Gross ProfitEUR 5.15B
    Operating IncomeEUR 1.77B
    Pretax IncomeEUR 1.40B
    Net IncomeEUR 822.76M
    EBITDAEUR 2.97B
    EBITEUR 1.77B

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 40.67% of the EUR 31.45B in total assets.

    Working CapitalEUR -65.59M
    Shareholder EquityEUR 12.79B
    Tangible Book ValueEUR -2.48B
    Total AssetsEUR 31.45B
    Total LiabilitiesEUR 17.69B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After EUR 1.08B of capital spending, operating cash flow left EUR 1.78B of free cash flow.

    Operating Cash FlowEUR 2.86B
    Capital ExpendituresEUR 1.08B
    Free Cash FlowEUR 1.78B
    Depreciation and AmortizationEUR 1.63B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.06%, against a 5-year average of 8.45%.

    Gross Margin26.46%
    Operating Margin9.06%
    Pretax Margin7.20%
    Net Margin4.22%
    EBITDA Margin15.27%
    EBIT Margin9.11%
    FCF Margin9.14%
    Gross Margin (5Y Average)25.57%
    Operating Margin (5Y Average)8.45%
    Net Margin (5Y Average)3.86%

    Growth

    Revenue grew 0.39% a year over 3 years.

    Revenue Growth (3Y CAGR)+0.39%
    Revenue Growth (5Y CAGR)+1.91%
    FCF Growth (3Y CAGR)+30.91%
    FCF Growth (5Y CAGR)-4.59%
    Operating Income Growth (3Y CAGR)+6.51%

    Revenue and profit by year

    Dividends and Yields

    FMS pays out 48.06% of earnings as dividends.

    Dividend Per Share (Annual)$0.87
    Dividend Yield4.02%
    Payment ScheduleAnnual
    Dividend Growth (3Y CAGR)+4.74%
    Dividend Growth (5Y CAGR)+2.88%
    Payout Ratio48.06%
    Earnings Yield11.36%
    FCF Yield18.01%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Dec 4, 2012.

    Last Split DateDec 4, 2012
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, FMS has the 12th highest P/E and the lowest P/S.

    P/E Ratio8.8x vs 23.6x median
    P/S Ratio0.5x vs 1.6x median
    ROIC6.88% vs 12.96% median
    Revenue Growth (Trailing 4 Quarters, YoY)-0.83% vs +7.19% median
    Dividend Yield4.02% vs 0.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FMS

    What is FMS's market cap?

    Fresenius Medical Care has a market cap of $11.43B.

    What is FMS's P/E ratio?

    Fresenius Medical Care has a trailing P/E ratio of 8.8x.

    How many shares of FMS are outstanding?

    Fresenius Medical Care has 524.00M shares outstanding. The count is down 10.38% from a year earlier.

    Does FMS pay a dividend?

    Yes. Fresenius Medical Care pays $0.87 a share a year, a dividend yield of 4.02%.